Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
CMMB
CMMB
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CMMB News
Chemomab and Scipher Merge to Advance RA Drug Development
8h ago
Newsfilter
Chemomab and Scipher Enter Definitive Merger Agreement
6h ago
seekingalpha
Biotech Companies See Significant Stock Gains
5d ago
NASDAQ.COM
Biotech Stocks Surge with Akari Leading the Rally
May 26 2026
NASDAQ.COM
Chemomab Therapeutics Reports Q1 Financial Results
May 14 2026
seekingalpha
Chemomab Therapeutics Reports Q4 Financial Results
Mar 19 2026
seekingalpha
Market Update: Tilray Drives After-Hours Gains as Biotech Stocks Soar
Dec 15 2025
NASDAQ.COM
Top Strong Buy Stocks for October 23: MQ, GES, and Others
Oct 23 2025
NASDAQ.COM
VTYX, MEDP, INBX Surge in After-Hours Trading Following Important Announcements
Oct 23 2025
NASDAQ.COM
ESPR Seeks Diversification Through Rare Liver Disease Candidate, Shares Rise
Oct 17 2025
NASDAQ.COM
CDTX Shares Rise Following FDA's Breakthrough Therapy Designation for CD388 in Influenza
Oct 10 2025
NASDAQ.COM
Oppenheimer Reiterates Outperform Rating for Chemomab Therapeutics and Increases Price Target to $25
Aug 27 2025
Benzinga
Stock Splits Scheduled for This Week (August 25 to August 29) – Keep Your Investments Active
Aug 24 2025
TipRanks
Chemomab Announces Oral Presentation of Positive Nebokitug Phase 2 Clinical Data in Primary Sclerosing Cholangitis at BSG Live'25
Jun 30 2025
Newsfilter
Chemomab Reports Positive Feedback From Two Recent FDA Meetings Supporting Phase 3 Advancement of Nebokitug in Primary Sclerosing Cholangitis
Jun 11 2025
Newsfilter
KURA Stock Rises More Than 15% This Past Week: Here's Why
Jun 06 2025
NASDAQ.COM
Show More News
